Update

Update

Backed into a corner, Hyflux remains uncertain over plans to extend debt moratorium

SINGAPORE (April 11): Hyflux remains undecided over the possibility of seeking an extended debt moratorium ahead of the April 30 deadline, according to the troubled water and power company’s repres

Update

Rare Singapore protest flags investor anger in Hyflux slump

SINGAPORE (April 1): A rare public protest in Singapore on Saturday underscored mounting anger among investors set to suffer sharp losses in one of the country’s highest-profile corporate debt rest

Update

YuuZoo CEO 'forced to quit' as company closes subsidiaries in Singapore, terminates employments

SINGAPORE (Mar 18): The chief operating officer (CEO) and executive director of YuuZoo Networks Group, formerly known as YuuZoo Corporation, resigned effective today.

Update

Hyflux postpones third town hall; cites space issues due to 'large number' of expected attendees

SINGAPORE (Mar 12): Hyflux is postponing its town hall meeting indefinitely as the group says the venue cannot accommodate the “large number” of shareholders and noteholders who said they wished to

Update

Raffles Education scraps $27.4 mil rights issue in view of recent market conditions, share price falls

SINGAPORE (Mar 6): Raffles Education Corp is cancelling its proposed 2-for-10 rights issue, which would have allowed the group to raise up to about $27.4 million in net proceeds after raising 275.9

Update

Datapulse slapped with writ of summons by ex-directors after partial payment of claim

SINGAPORE (Feb 26): Three former executive directors of Datapulse Technology have commenced legal action against the company for a balance sum of their original demand.

Update

Singapore Medical Group announces $50 mil share purchase from existing shareholder CHA

SINGAPORE (Feb 20): Singapore Medical Group (SMG) says its 6.86% shareholder CHA Healthcare Singapore (CHAS) is increasing its stake in the group to 24.13% by purchasing existing shares from certai

Update

Procurri falls 9.7% to 28 cents as New State also withdraws acquisition offer

SINGAPORE (Feb 19): Shares of Procurri Corporation fell on Tuesday morning after it announced that potential investor New State Capital Partners had withdrawn its

Update

iX Biopharma disposes of Australian lab testing business for $12 mil after 2Q losses

SINGAPORE (Feb 18): iX Biopharma is selling Chemical Analysis, its laboratory testing business in Australia, to Eurofins Australia New Zealand Holding for A$12.5 million ($12 million).  

Update

Second potential offeror rescinds expression of interest to acquire Procurri less than 24 hours later

SINGAPORE (Feb 8): Procurri Corporation says the second potential offeror to express interest in acquiring the company after New State Capital Partners LLC has now decided to terminate further disc

Be informed of the stories that matter

×